Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis A Randomized Clinical Trial

Autor: Laar, J.M. van, Farge, D., Sont, J.K., Naraghi, K., Marjanovic, Z., Larghero, J., Schuerwegh, A.J., Marijt, E.W.A., Vonk, M.C., Schattenberg, A.V., Matucci-Cerinic, M., Voskuyl, A.E., Loosdrecht, A.A. van de, Daikeler, T., Kotter, I., Schmalzing, M., Martin, T., Lioure, B., Weiner, S.M., Kreuter, A., Deligny, C., Durand, J.M., Emery, P., Machold, K.R., Sarrot-Reynauld, F., Warnatz, K., Adoue, D.F.P., Constans, J., Tony, H.P., Papa, N. del, Fassas, A., Himsel, A., Launay, D., Monaco, A. lo, Philippe, P., Quere, I., Rich, E., Westhovens, R., Griffiths, B., Saccardi, R., Hoogen, F.H. van den, Fibbe, W.E., Socie, G., Gratwohl, A., Tyndall, A., EBMT EULAR Scleroderma Study Grp

Publikováno v: van Laar, J M, Farge, D, Sont, J K, Naraghi, K, Marjanovic, Z, Larghero, J, Schuerwegh, A J, Marijt, E W A, Vonk, M C, Schattenberg, A V, Matucci-Cerinic, M, Voskuyl, A E, van de Loosdrecht, A A, Daikeler, T, Kotter, I, Schmalzing, M, Martin, T, Lioure, B, Weiner, S M, Kreuter, A, Deligny, C, Durand, J M, Emery, P, Machold, K R, Sarrot-Reynauld, F, Warnatz, K, Adoue, D F P, Constans, J, Tony, H P, Del Papa, N, Fassas, A, Himsel, A, Launay, D, Lo Monaco, A, Philippe, P, Quere, I, Rich, E, Westhovens, R, Griffiths, B, Saccardi, R, van den Hoogen, F H, Fibbe, W E, Socie, G, Gratwohl, A & Tyndall, A 2014, ' Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis A Randomized Clinical Trial ', JAMA, vol. 311, no. 24, pp. 2490-2498 . https://doi.org/10.1001/jama.2014.6368
Journal of the American Medical Association, 311(24), 2490-2498
Jama : Journal of the American Medical Association, 311, 2490-8
Jama : Journal of the American Medical Association, 311, 24, pp. 2490-8
JAMA, 311(24), 2490-2498. American Medical Association

Contains fulltext : 136804.pdf (Publisher’s version ) (Open Access) IMPORTANCE: High-dose immunosuppressive therapy and autologous hematopoietic stem cell transplantation (HSCT) have shown efficacy in systemic sclerosis in phase 1 and small phase 2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::391617a24aaba7a2a180612542c8128f
https://hdl.handle.net/1887/103060